Specifically, low A-SMase in melanoma accounts for the high expression of factors involved in inflammation (i.e., IL-1β, IL-6, GM-CSF, and TNF-α), which have been positively associated with cancer onset and progression [6, 34]. This evidence concerns the gene CSF2 and cancer.